Updates are available Correction dated 2021-10-08
Click to view Correction: https://doi.org/10.1038/s41591-021-01569-2
-
Authors
Kyriazopoulou, Evdoxia http://orcid.org/0000-0002-9585-517X
Poulakou, Garyfallia
Milionis, Haralampos
Metallidis, Simeon
Adamis, Georgios
Tsiakos, Konstantinos http://orcid.org/0000-0002-9167-905X
Fragkou, Archontoula
Rapti, Aggeliki
Damoulari, Christina
Fantoni, Massimo http://orcid.org/0000-0001-6913-8460
Kalomenidis, Ioannis http://orcid.org/0000-0001-9729-3492
Chrysos, Georgios
Angheben, Andrea http://orcid.org/0000-0003-4545-8034
Kainis, Ilias
Alexiou, Zoi
Castelli, Francesco
Serino, Francesco Saverio
Tsilika, Maria
Bakakos, Petros
Nicastri, Emanuele
Tzavara, Vassiliki
Kostis, Evangelos
Dagna, Lorenzo http://orcid.org/0000-0002-7428-315X
Koufargyris, Panagiotis http://orcid.org/0000-0001-7800-3306
Dimakou, Katerina
Savvanis, Spyridon
Tzatzagou, Glykeria
Chini, Maria
Cavalli, Giulio
Bassetti, Matteo
Katrini, Konstantina
Kotsis, Vasileios
Tsoukalas, George
Selmi, Carlo
Bliziotis, Ioannis
Samarkos, Michael http://orcid.org/0000-0001-9630-9712
Doumas, Michael
Ktena, Sofia
Masgala, Aikaterini
Papanikolaou, Ilias http://orcid.org/0000-0003-1391-2925
Kosmidou, Maria http://orcid.org/0000-0002-8618-9435
Myrodia, Dimitra-Melia
Argyraki, Aikaterini
Cardellino, Chiara Simona
Koliakou, Katerina
Katsigianni, Eleni-Ioanna
Rapti, Vassiliki
Giannitsioti, Efthymia
Cingolani, Antonella
Micha, Styliani
Akinosoglou, Karolina
Liatsis-Douvitsas, Orestis http://orcid.org/0000-0002-0927-920X
Symbardi, Styliani
Gatselis, Nikolaos
Mouktaroudi, Maria
Ippolito, Giuseppe http://orcid.org/0000-0002-1076-2979
Florou, Eleni http://orcid.org/0000-0002-1201-099X
Kotsaki, Antigone
Netea, Mihai G. http://orcid.org/0000-0003-2421-6052
Eugen-Olsen, Jesper http://orcid.org/0000-0002-4630-4275
Kyprianou, Miltiades http://orcid.org/0000-0003-1260-1789
Panagopoulos, Periklis
Dalekos, George N.
Giamarellos-Bourboulis, Evangelos J. http://orcid.org/0000-0003-4713-3911
-
Funding
Funding for this research was provided by:
Hellenic Institute for the Study of Sepsis Swedish Orphan BioVitrum AB
- License Information
-
More Information
Article History
Received: 22 June 2021
Accepted: 10 August 2021
First Online: 3 September 2021
Change Date: 8 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-021-01569-2
Competing interests
: G.P. has received independent educational grants from Pfizer, MSD, Angelini and Bio-Rad. H.M. reports receiving honoraria, consulting fees and non-financial support from healthcare companies, including Amgen, Angelini, Bayer, Mylan, MSD, Pfizer and Servier. L.D. received consultation honoraria from Sobi. M.B. has received funds for research grants and/or advisor/consultant and/or speaker/chairman from Angelini, Astellas, Bayer, bioMérieux, Cidara, Cipla, Gilead, Menarini, MSD, Pfizer, Roche, Shionogi and Nabriva. M.G.N. is supported by an ERC Advanced Grant (no. 833247) and a Spinoza grant of the Netherlands Organization for Scientific Research. He has also received independent educational grants from TTxD, GSK and ViiV Healthcare. J.E.-O. is a co-founder, shareholder and CSO of ViroGates, Denmark, and is a named inventor on patients on suPAR owned by Copenhagen University Hospital Hvidovre, Denmark. P.P. has received honoraria from Gilead, Janssen and MSD. G.N.D. is an advisor or lecturer for Ipsen, Pfizer, Genkyotex, Novartis and Sobi, has received research grants from Abbvie and Gilead and has served as principal investigator in studies for Abbvie, Novartis, Gilead, Novo Nordisk, Genkyotex, Regulus Therapeutics, Tiziana Life Sciences, Bayer, Astellas, Pfizer, Amyndas Pharmaceuticals, CymaBay Therapeutics, Sobi and Intercept Pharmaceuticals. E.J.G.-B. has received honoraria from Abbott, bioMérieux, Brahms, GSK, InflaRx, Sobi and XBiotech; independent educational grants from Abbott, AxisShield, bioMérieux, InflaRx, Johnson & Johnson, MSD, Sobi and XBiotech; and funding from the Horizon 2020 Marie-Curie Project European Sepsis Academy (granted to the National and Kapodistrian University of Athens) and the Horizon 2020 European Grants ImmunoSep and RISKinCOVID (granted to the Hellenic Institute for the Study of Sepsis). The other authors do not have any competing interests to declare.
